![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/39 | |
A61K 38/00 | |||
C07K 14/78 | |||
A61P 35/00 | |||
A61K 39/395 | |||
C07K 16/28 | |||
A61K 45/06 |
(11) | Patento numeris | 2922566 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13856353.1 |
Europos patento paraiškos padavimo data | 2013-11-21 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-09-30 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-03 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2013/071267 |
Data | 2013-11-21 |
(87) | Numeris | WO 2014/081944 |
Data | 2014-05-30 |
(30) | Numeris | Data | Šalis |
201261728906 P | 2012-11-21 | US | |
201261728914 P | 2012-11-21 | US | |
201261728912 P | 2012-11-21 | US | |
201361782550 P | 2013-03-14 | US | |
201361809541 P | 2013-04-08 | US |
(72) |
ANDERSON, Mark, US
ATTAR, Ricardo, US
DIEM, Michael, US
HYUN, Linus, US
JACOBS, Steven, US
KING, Alastair, US
KLEIN, Donna, US
MOORES, Sheri, US
O`NEIL, Karyn, US
PICHA, Kristen, US
|
(73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
(54) | EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES |
EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES |